A key component in the creation of sustainable processes is the design of novel biocatalysts that increase the stability and reusability of enzymes by immobilization. This study successfully designed an α-amylase biocatalyst using the co-precipitation approach, based on Zn-Al-layered double-hydroxide (LDH) nanoparticles (NPs). The enzymatic activity of the immobilized α-amylase (LDH/Amy) with a particle size of 255 +/- 36 nm was maintained with a high immobilization yield of 97% and an intermediate loading capacity of about 54.81 mg/g of enzyme/LDH. Zeta potential analysis showed that electrostatic interactions influenced enzyme immobilization on the LDH NPs. LDH/Amy exhibited higher Km and increased Vmax, indicating enhanced catalytic activity. Studies on thermal stability revealed that LDH/Amy was more resistant than the free form. Reduction of the activation energy and enhancement of the half-life (T1/2) revealed improved stability of LDH/Amy. In addition, LDH/Amy maintained 90% of its initial activity following 5 consecutive runs and 97.6% of its initial activity following a 25-day storage period. The findings presented in this study indicate the potential utility of LDH NPs as an ecologically benign, low-cost biocatalyst that can promote α-amylase in the hydrolysis of starch for use in pharmaceutical and industrial processes.
No takes yet. Share an insight, caveat, or question.
Mageed et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: